Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
Clinical trial NCT06595706 · COMPLETED
Trial details
- NCT number
- NCT06595706
- Sponsor
- Huge Biopharma Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-28
- Primary completion
- 2025-01-24
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.